Zealand Pharma A/S
Zealand Pharma A/S expects to issue Prospectus Supplement no. 2 to prospectus dated 3 November 2010 containing information about revised offer size and narrowed price range
Zealand Pharma A/S 18.11.2010 17:19 --------------------------------------------------------------------------- NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, OR JAPAN For further information, please contact: Zealand Pharma A/S David Solomon, President and Chief Executive Officer Tel: +45 4328 1200 M:Communications Mary-Jane Elliott / Emma Thompson / Amber Bielecka Tel: +44(0) 20 7920 2330 News Source: NASDAQ OMX 18.11.2010 Dissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Zealand Pharma A/S DK Phone: Fax: E-mail: Internet: WKN: End of Announcement DGAP News-Service ---------------------------------------------------------------------------
Latest News
Latest Reports
No Reports found
Upcoming Events
No Events found
Webcasts
No Webcasts found